国产熟女口爆颜射自拍_国产特黄无码毛片_亚洲成a人片77777在线播放_韩国伦理午夜福利_国产免费观看av大片的网站_网曝门欧美日韩私拍_又色又爽又湿视频在线观看_丁香五月开心婷婷综合缴情_久久国产精品明星换脸_人成午夜免费高潮在线

Your location:Home - News - Industry dynamics
Reprint: Analysis of driving factors of hyaluronic acid industry in China in 2024
Release time:2024-07-29 10:35:38      Clicks:381

Core data: market size; Per capita consumption; Regulatory trend

1, China's hyaluronic acid raw materials monopoly of more than 80% of the global market share

China is the world's largest raw material market for hyaluronic acid, and domestic enterprises occupy more than 80% of the global market. From the sales point of view, the market size of hyaluronic acid raw materials in China in 2023 is about 4.71 billion yuan, an increase of 9.0%, and the CAGR from 2017 to 2023 is 10.5%. From the sales volume, the market size of hyaluronic acid raw materials in China in 2023 is about 793.0 tons, an increase of 15.9%, and the CAGR from 2017 to 2023 is 14.0%.

圖片1.jpg

2. "Silver economy" further opens the demand window for pharmaceutical grade hyaluronic acid

Hyaluronic acid benefits from good physical and chemical properties, and is widely used in various biomedical materials in orthopedics, ophthalmology and other fields. Under the background of the domestic silver economy, the number of diseases such as osteoarthritis and cataract has increased, which has led to a high demand for hyaluronic acid medical materials. The prevalence of arthritis in the elderly population aged 65 and above is more than 50%, and the proportion of cataract in the elderly aged 65 and above is more than 70%. At present, China has entered an aging society, and the number and proportion of the elderly population aged 65 and above are increasing year by year. In 2023, the number of elderly people aged 65 and above in China is about 220 million, accounting for 15.4% of the total population, and the CAGR from 2014 to 2023 will be 5.0%. With the accelerating aging process, the number of patients with eye diseases such as arthritis and cataracts continues to rise, and the demand for medical hyaluronic acid continues to increase, promoting the demand window for pharmaceutical grade hyaluronic acid to further open.

圖片2.jpg

3, the "appearance level economy" drives the stable development of uric acid medical beauty projects and functional skin care needs

In the field of medical cosmetology, hyaluronic acid is widely used, whether injection, external application or internal administration, hyaluronic acid has excellent effects, in 2022 China's medical cosmetology market of about 226.8 billion yuan, an increase of 20%, 2017 to 2022 CAGR of 18%. In the field of functional skin care products, China's functional skin care products mainly target at sensitive muscle repair and effective hydration and moisturizing, while hyaluronic acid is the primary core ingredient in functional skin care products, China's functional skin care products market in 2022 is about 41.9 billion yuan, an increase of 36% year-on-year, and the CAGR from 2017 to 2022 is 26%.

圖片3.jpg

4, the consumption power of Chinese people is growing, and the consumption willingness of medical and American medicine continues to improve

Hyaluronic acid, as a classic of light medicine and beauty injection project, is favored in our country. Compared with surgery, the light medical beauty represented by injection has fast recovery time, relatively low price and risk, so it has higher market acceptance and re-purchase rate. In recent years, China's economy has developed rapidly, and the per capita consumption expenditure of Chinese residents has continued to increase, reaching 26,800 yuan/year in 2023, with a CAGR of 7% from 2017 to 2023, and the per capita consumption expenditure on services in 2023 will be 12,114 yuan/year, accounting for 5.21% of the per capita consumption expenditure. In this context, Chinese residents' ability to pay for hyaluronic acid has significantly improved. With the increasing popularity of non-surgical medical cosmetic programs such as hyaluronic acid injection, Chinese residents have gradually begun to accept "light medicine" and are willing to try it.

圖片4.jpg

5, stricter regulatory policies to promote the healthy development of hyaluronic acid industry

China's medical devices adopt a classified supervision model, of which the third type of medical devices have the highest degree of risk, so the supervision is the most stringent, whether it is production or operation, there is a high entry threshold, the need to obtain medical device registration certificate issued by the relevant departments, medical device production license and medical device business license. Hyaluronic acid for medical and medical cosmetology belongs to the third class of medical devices, so its production and management are strictly regulated.

圖片5.jpg

Last:Reprint: Medical devices are also widely known as life science devices
Next:Reprint: Qianzhan Network "2024 China Ophthalmic high-value Consumables Industry Panorama"

Return